Comprehensive CDMO solutions from preclinical to commercial
We focus on addressing our clients' most critical and complex drug discovery and development challenges. With our specialized knowledge, technical expertise, and highly reputed quality of service, we are indispensable in transforming our services into solutions tailored to your needs from pre-clinical and commercial analytical development to process development, manufacturing, and quality control.
Veliter’s VPS™ （Veliter Preclinical Service）provides affordable, quality oligonucleotides with fast turnaround times. Our team specializes in small batch sizes at μmol- to mmol-scales, from 50 mg to 10’s of grams of oligonucleotides for research and early pre-clinical applications to facilitate your program successful.
Veliter’s analytical development is the premier choice for analytical services covering all stages of drug development. Our 10’s years of analytical experience with oligonucleotides, together with our practical instrumentation, ensure reliable results to facilitate your program’s success.
Based on our best-view platform, Veliter’s Process Development offers industry-leading development services to solutions tailored to individual customer needs, from the lab to validation and commercial manufacture. Our experts team will ensure our approaches are aligned with regulatory guidelines and GMP industry best practices.
Premier partner from preclinical to commercial supply – Veliter is one of few real Oligonucleotide CDMO across the world currently. We have the flexibility to provide your first preclinical non-GMP oligonucleotide, from mgs to 10’s of grams, and more than hundred of kilograms of GMP oligonucleotide in support of your commercial supply.
Veliter is an expert partner handling the entire process—from API (drug substance) development through fill finish manufacturing of drug product—with consistent quality. Veliter’s formulation department offers you a comprehensive and a seamless end-to-end oligonucleotide manufacturing solution to deliver your fill and finish needs for your project’s success.
Ensure clearing to commercial manufacturing – Based on the requirement of consistency and reproducibility in pharmaceutical manufacture, Veliter’s risk-based approach is to use the current guidelines and standards for validation and Process Performance Qualification (PPQ).
Understanding the vital role that quality control testing and stability study play in all facets of your project, Veliter’s QC group has the expertise and resources for you to keep your project on track.
Our Awards
Positive oligo program experience, from end to end
Focusing on your needs and building long-term partnerships, your own Veliter’s project manager will be flexible and responsive. This is Veliter’s approach to make your oligonucleotide program move smoothly through pre-clinical to commercial.
